S4 E16, Allisa Song & Mackenzie Andrews from Mu Medical

Rethinking Eye Care: From NanoDropper to Mu MedicalWhat started as a student project has turned into a company reshaping how eye care is delivered.In this episode of She Leads Biotech, we’re joined by Allisa Song, CEO of Mu Medical, and Mackenzie Andrews, CCO, to talk about the journey from an idea sparked in a research lab to a product now used across thousands of clinics.They share how a simple question, why are eye drops too big, led to a solution that improves patient outcomes, reduces waste, and is now evolving into something much bigger.We also get into co-founder dynamics, building in a complex healthcare system, and the reality of being young female leaders in a traditionally male-dominated space.A practical, honest conversation about building, scaling, and challenging assumptions in healthcare.Chapters00:00 Introduction01:30 Meet Allisa & Mackenzie04:00 From Research Lab to Startup Idea08:30 The Eye Drop Problem Explained13:00 Building NanoDropper18:30 When It Became a Real Business22:00 Product Demo & Clinical Impact26:00 Go-to-Market Strategy30:00 Working with Insurers, Clinics & Pharma34:00 Evolving into Mu Medical38:00 Co-Founder Dynamics & Trust42:00 Being Women in a Male-Dominated Industry47:00 Advice for Founders51:00 What’s Next for Mu MedicalListen / Watch:Spotify | YouTube#SheLeadsBiotech #MedTech #HealthcareInnovation #WomenInBiotech #CNAUSAExecutiveSearch